Experimental nerve treatment offers hope for chronic pain sufferers
NCT ID NCT04153422
Summary
This study is testing whether intravenous immunoglobulin (IVIG) can help people with autoimmune small fiber neuropathy, a condition that causes chronic pain and nerve damage. Researchers will give 20 participants either IVIG or a placebo for six months to see if it reduces pain and helps nerves regrow. The goal is to find a better treatment option for this painful condition that currently has no standard cure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL-FIBER NEUROPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
Endeavor Health
RECRUITINGGlenview, Illinois, 60026, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.